Seralutinib improves pulmonary arterial blood vessel volume distribution in pulmonary arterial hypertension: Results of the TORREY Phase 2 imaging substudy
Seralutinib improves pulmonary arterial blood vessel volume distribution in pulmonary arterial hypertension: Results of the TORREY Phase 2 imaging substudy
WSPH – June 2024a
Now Enrolling: The PROSERA Phase 3 study of seralutinib in adults with Pulmonary Arterial Hypertension (PAH).
